Abstract
The incidence of non-Hodgkin's lymphoma (NHL) has been increasing rapidly over the last three decades. The reasons for this trend are not known although increasing exposure to sunlight has been postulated. We used data from the New South Wales Central Cancer Registry to analyse second primary neoplasms following NHL diagnosed between 1972 and 1995, to identify possible common causal agents. A total of 12 452 patients contributed 54 308 person-years of follow-up during which time there were 705 second primary neoplasms compared to 592.99 expected (standardized incidence ratio (SIR = 1.19, 95% confidence interval (CI) 1.10–1.28). There were excesses of melanomas of skin (SIR = 2.38, 95% CI 1.92–2.91), lip cancer (SIR = 2.74, 95% CI 1.59–4.38), tongue cancer (SIR = 2.53, 95% CI 1.09–4.99) and bladder cancer (SIR = 1.64, 95% CI 1.19–2.21). There was also over a threefold excess in soft tissue sarcomas (SIR = 3.61, 95% CI 1.80–6.45) and in thyroid cancer (SIR = 3.42, 95% CI 1.56–6.49). The SIR for myeloid leukaemia was 0.78 (95% CI 0.28–1.69). The increases in melanoma of the skin and cancer of the lip and tongue among patients with NHL strongly suggest sunlight exposure as a shared causal agent. The increase in soft tissue sarcomas might be due to shared effects of exposure to chemicals such as phenoxy acid herbicides. The increases in bladder and thyroid cancers are likely to be explained by effects of treatment for NHL. We did not find a chemotherapy related increased risk of myeloid leukaemia among NHL patients. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Boffetta P, Butler J, Maynadie M and Brennan P (1999) Lymphomas. In: Multiple Primary Cancers, Neuget AT, Robinson E, Meadows (eds). Lippincott Williams and Wilkins, Philadelphia
Cartwright RA (1992) Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britian? Cancer Res 52: 5441s–5442s
Cartwright R, McNally R and Staines A (1994) The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymph 14: 387–394
Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N and Saracci R (1997) Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol 145: 1061–1075
Kraemer KH, Lee MM, Andrews AD and Lambert WC (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130: 1018–1021
McMichael AJ and Giles GG (1996) Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 73: 945–950
Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J and Powell J (eds) (1992) Cancer Incidence in Five Continents, Vol. VI. IARC Scientific Publications No. VI, IARC Scientific Publications No. 120, IARC: Lyon
Parkin DM, Whelan SL, Ferlay J, Raymond L and Young J (eds) (1997) Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publications No. 143. IARC: Lyon
Rolland-Portal I, Tazi MA, Milan C, Couillault C and Carli PM (1997) Non-Hodgkin's lymphoma: time trends for incidence and survival in Cote-d'Or, France. Int J Epidemiol 26: 945–952
Ron E (1996) Thyroid cancer. Cancer epidemiology and prevention, Schottenfeld D, Fraumeni J (eds) pp 1000–1021. Oxford University Press: New York
Scotto J, Fears TR and Fraumeni JR (1996) Solar radiation. Cancer epidemiology and prevention, Schottenfeld D, Fraumeni JR (eds) pp 355–372. Oxford University Press: New York
Travis LB, Curtis RE, Boice JNJD, Hankey BF and Fraumeni JF Jr (1991) Second cancers following non-Hodgkin's lymphoma. Cancer 67: 2002–2009
Travis LB, Curtis RE, Stovall M, Holowaty EJ, van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY and Banks PM (1994) Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst 86: 1450–1457
Travis LB, Curtis RE, Glimelius B, Holowaty EJ, van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM and Adami J (1995) Bladder and kidney cancers following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 87: 524–530
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Brennan, P., Coates, M., Armstrong, B. et al. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 82, 1344–1347 (2000). https://doi.org/10.1054/bjoc.1999.1102
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1102
Keywords
This article is cited by
-
Correlation study of malignant lymphoma and breast Cancer in different gender European populations: mendelian randomization analysis
BMC Genomic Data (2023)
-
Induction of B-cell lymphoma by UVB Radiation in p53 Haploinsufficient Mice
BMC Cancer (2011)
-
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma
British Journal of Cancer (2005)
-
Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland
British Journal of Cancer (2003)